Alogliptin and Urinary tract infection - a phase IV clinical study of FDA data

Summary:

Urinary tract infection is reported as a side effect among people who take Alogliptin (alogliptin benzoate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Metformin, and have Diabetes.

The phase IV clinical study analyzes which people have Urinary tract infection when taking Alogliptin. It is created by eHealthMe based on reports of 1,922 people who have side effects when taking Alogliptin from the FDA, and is updated regularly.

What is Alogliptin?

Alogliptin has active ingredients of alogliptin benzoate. eHealthMe is studying from 1,943 Alogliptin users. Check the latest studies of Alogliptin.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,013 drugs and 3,957 conditions by eHealthMe. Check the latest studies of Urinary tract infection.

On Jul, 13, 2026

1,922 people reported to have side effects when taking Alogliptin.
Among them, 24 people (1.25%) have Urinary tract infection.

Could Alogliptin cause Urinary tract infection?

Among these 24 people:

How long have people been on Alogliptin when they have Urinary tract infection? *

What is the gender of people who have Urinary tract infection when taking Alogliptin? *

female: 52.17 %
male: 47.83 %

What is the age of people who have Urinary tract infection when taking Alogliptin? *

What are other drugs people take besides Alogliptin? *

Metformin: 11 people, 45.83%
Gliclazide: 8 people, 33.33%
Dapagliflozin: 8 people, 33.33%
Fenofibrate: 7 people, 29.17%
Omeprazole: 7 people, 29.17%
Phenytoin: 7 people, 29.17%
Atenolol: 7 people, 29.17%
Tylenol: 3 people, 12.50%
Metformin Hydrochloride: 3 people, 12.50%
Acetaminophen: 3 people, 12.50%

What are other side effects people have besides Urinary tract infection? *

Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 7 people, 29.17%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 16.67%
Diarrhea: 3 people, 12.50%
Necrotising Fasciitis (an uncommon life-threatening soft-tissue infection): 2 people, 8.33%
Renal Tubular Necrosis (death of kidney tubules): 2 people, 8.33%
Renal Injury (kidney injury): 2 people, 8.33%
Itching: 2 people, 8.33%
Leukocytosis (increased white blood cells): 2 people, 8.33%
Dizziness: 1 person, 4.17%
Fungal Infection: 1 person, 4.17%

What are the existing conditions these people have? *

Diabetes: 6 people, 25.00%
Type 2 Diabetes: 5 people, 20.83%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 4.17%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 1 person, 4.17%
Infective Spondylitis (infective inflammation of a spinal joint; characterized by pain and stiffness): 1 person, 4.17%
High Blood Pressure: 1 person, 4.17%
High Blood Cholesterol: 1 person, 4.17%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 4.17%
Depressed Mood: 1 person, 4.17%
Constipation: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Alogliptin and have Urinary tract infection?

- Check whether Urinary tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alogliptin:

Alogliptin (1,943 reports)

Browse all side effects of Alogliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary tract infection:

Urinary tract infection (3,013 drugs)

Browse all the conditions that are associated with Urinary tract infection:

Urinary tract infection (3,957 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alogliptin benzoate (the active ingredients of Alogliptin) and Alogliptin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.